Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-215735
Filing Date
2004-12-17
Accepted
2004-12-17 17:18:21
Documents
11
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS d10k.htm 10-K 855388
2 TERMS OF OUTSIDE DIRECTOR COMPENSATION dex10114.htm EX-10.114 3523
3 LIST OF SUBSIDIARIES dex211.htm EX-21.1 808
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1728
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 1612
6 CERTIFICATION dex311.htm EX-31.1 10013
7 CERTIFICATION dex312.htm EX-31.2 10238
8 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3477
9 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3496
10 GRAPHIC g71872img001.jpg GRAPHIC 12836
11 GRAPHIC g71872img002.jpg GRAPHIC 36730
  Complete submission text file 0001193125-04-215735.txt   942845
Mailing Address PO BOX 14287 RTP NC 27709-4287
Business Address PO BOX 14287 RTP NC 27709-4287 9195588688
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-50481 | Film No.: 041212133
SIC: 2834 Pharmaceutical Preparations